Neuphoria Therapeutics Inc.
NEUP
Rangering i aksjer
#29272
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aksjekurs
$3.92
Sist synkronisert: 2026-07-31
Markedsverdi
$21.16M
Endring (1 dag)
-0.13%
Endring (1 år)
60,767.52%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Markedsverdi av Neuphoria Therapeutics Inc.(NEUP)
Markedsverdi: $21.16M
Per October 2026 har Neuphoria Therapeutics Inc. en markedsverdi på $21.16M. Dette gjør Neuphoria Therapeutics Inc. til det 29272nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Neuphoria Therapeutics Inc. fra 1999 til 2026
NEUP sammenlignet med topp 5 mest populære stocks
| Pris på NEUP | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$879,305
$37.80K
|
$5.167T | +13,670,779,409.98% | ||
|
$853,394
$37.80K
|
$5.015T | +13,267,932,835.91% | ||
|
$699,150
$37.80K
|
$4.108T | +10,869,871,429.06% | ||
|
$664,009
$37.80K
|
$3.902T | +10,323,524,771.42% | ||
|
$457,680
$37.80K
|
$2.689T | +7,115,671,648.61% |
